Mfrdmanager: /* Succinycholine */

2019-09-13T15:10:20Z

‎Succinycholine

Mfrdmanager: Created page with "==Section 8 - MEDICATION GUIDELINES== ===8.18 PARALYTIC=== ====Succinycholine==== '''DESCRIPTION''' * A skeletal muscle relaxant for intravenous (IV) administration indicate..."

2019-09-13T15:07:30Z

Created page with "==Section 8 - MEDICATION GUIDELINES== ===8.18 PARALYTIC=== ====Succinycholine==== '''DESCRIPTION''' * A skeletal muscle relaxant for intravenous (IV) administration indicate..."

New page

==Section 8 - MEDICATION GUIDELINES==
===8.18 PARALYTIC===

====Succinycholine====

'''DESCRIPTION'''
* A skeletal muscle relaxant for intravenous (IV) administration indicated as an adjunct to general anesthesia, to facilitate tracheal intubation, and to provide skeletal muscle relaxation during surgery or mechanical ventilation.
'''INDICATIONS'''
* [[Drug Assisted Intubation]].
'''CONTRAINDICATIONS'''
* Do not administer to patients with Hx of HYPERKALEMIA, RHABDOMYOLYSIS, Severe Burns and Malignant hyperthermia. (i.e. peaked T waves, kidney insufficiency, renal failure, acidosis, crush injuries.)
'''DOSAGE'''
* 0.3-1.1 mg/kg intravenously (IV) for 1 dose
* Maintenance for Prolonged Procedures - 0.04-0.07 mg/kg intravenously (IV) every 5-10 minutes as needed

[[Category:Medication Guidelines|0819]]

@@ Line 11: / Line 11: @@
 * Do not administer to patients with Hx of HYPERKALEMIA, RHABDOMYOLYSIS, Severe Burns and Malignant hyperthermia. (i.e. peaked T waves, kidney insufficiency, renal failure, acidosis, crush injuries.)
 '''DOSAGE'''
-* 0.3-1.1 mg/kg intravenously (IV) for 1 dose
+* 1.5 mg/kg intravenously (IV) for 1 dose
 * Maintenance for Prolonged Procedures - 0.04-0.07 mg/kg intravenously (IV) every 5-10 minutes as needed
 [[Category:Medication Guidelines|0819]]

Paralytic - Revision history

Mfrdmanager: /* Succinycholine */

Mfrdmanager: Created page with "==Section 8 - MEDICATION GUIDELINES== ===8.18 PARALYTIC=== ====Succinycholine==== '''DESCRIPTION''' * A skeletal muscle relaxant for intravenous (IV) administration indicate..."